Citation: | TANG Linfang, ZHANG Ziqiang, SU Rina, HE Shuwang, YAO Jing. Advances in taste-masking technology of oral paediatric medicine[J]. Journal of China Pharmaceutical University, 2017, 48(2): 135-141. DOI: 10.11665/j.issn.1000-5048.20170202 |
[1] |
Liu XY,Liu YQ.Study of a masking method to dispel the bitterness of macrolide-antibiotics and its application to prescriptions[J].J Peking Univ(北京大学学报),1997,29(3):236-237.
|
[2] |
Rider K,Stoss P.Vincamine saccharinate and a pharmaceutical composition containing it dissolved therein: US,4362730A[P].1982-12-07[2016-11-24] .
|
[3] |
Kugelmann H.Pharmaceutical tramadol salts: US,6723343B2[P].2004-04-20[2016-11-24] .
|
[4] |
Ogata T,Koide A,Kinoshita M,et al.Taste masking of propive-rine hydrochloride by conversion to its freenbase[J].Chem Pharm Bull,2012,60(8):976-984.
|
[5] |
Oksche A, Heath W, Holden T, et al. Buprenorphine-wafer for drug substitution therapy: US,9370512B2[P].2016-06-21[2016-11-24] .
|
[6] |
Aman RM,Meshali MM,Abdelghani GM.Ion-exchange complex of famotidine:sustained release and taste masking approach of stable liquid dosage form[J].Drug Discov Ther,2014,8(6):268-275.
|
[7] |
Sivaneswari S, Karthikeyan E, Veena D, et al. Physiochemical characterization of taste masking levetiracetam ion exchange resinates in the solid state and formulation of stable liquid suspension for pediatric use[J].Beni-Suef Univ J Basic Appl Sci,2016,5(2):126-133.
|
[8] |
Rajesh AM,Bhatt SA,Brahmbhatt H,et al.Taste masking of ciprofloxacin by ion-exchange resin and sustain release at gastric-intestinal through interpenetrating polymer network[J].Asian J Pharm Sci,2015,10(4):331-340.
|
[9] |
Kaushik D,Dureja H.Central composite designed taste masked ion exchange resinates for development of azithromycin dispersible tablets[J].J Pharm Res,2015,14(1):7-14.
|
[10] |
Puttewar TY,Kshirsagar MD,Chandewar AV,et al.Formulation andevaluation of orodispersible tablet of taste masked doxylamine succinate usingion exchange resin[J].King Saudi Univ Sci,2010,22(4):229-240.
|
[11] |
Dungarwal UN,Patil SB.Development of orodispersible tablets of taste masked rizatriptan benzoate using hydroxypropyl β cyclodextrin[J].J Pharm Investig,2016,46(6):537-545.
|
[12] |
Prabhakaran R,Harindran J.Formulation and evaluation of taste masked oral suspension of cefuroxime axetil using hydroxypropyl-beta-cyclodextrin[J].Asian J Pharm Clin Res,2016,9(2):279-285.
|
[13] |
Wei Y,Nedley MP,Bhaduri SB,et al.Masking the bitter taste of injectable lidocaine HCl formulation for dental procedures[J].AAPS Pharmscitech,2014,16(2):1-11.
|
[14] |
Xue LI,Guo Z,Hao JB,et al.Synergetic taste masking of lipid coating and β-cyclodextrin inclusion[J].Acta Pharm Sin(药学学报),2014,49(3):392-398.
|
[15] |
Ono N,Miyamoto Y,Ishiguro T,et al.Reduction of bitterness of antihistaminic drugs by complexation with β-cyclodextrins[J].J Pharm Sci,2011,100(5):1935-1943.
|
[16] |
Nishiyama T,Ogata T,Ozeki T.Preparation of bitter taste-masking granules of lafutidine for orally disintegrating tablets using water-insoluble/soluble polymer combinations[J].Drug Deliv Sci Tec,2016,32:38-42.
|
[17] |
Brniak W,Ma'slak E,Jachowicz R.Orodispersible films and tablets with prednisolone microparticles[J].Eur J Pharm Sci,2015,75:81-90.
|
[18] |
Paik DH,Jeong KY,Kim JH,et al.Edible HPMC films with indomethacin/HPMCP microparticles in oral delivery for taste-masking[J].Macromol Res,2014,22(11):1156-1159.
|
[19] |
Kondo K, Niwa T, Ozeki Y, et al. Preparation and evaluation of orally rapidly disintegrating tablets containing taste-masked particles using one-step dry-coated tablets technology[J].Chem Pharm Bull,2011,59(10):1214-1220.
|
[20] |
Petrovick GF,Breitkreutz J,Pein-Hackelbusch M.Taste-masking properties of solid lipid based micropellets obtained by cold extrusion-spheronization[J].Int J Pharm,2016,506(1):361-370.
|
[21] |
Refaat A,Sokar M,Ismail F,et al.A dual strategy to improve psychotic patients′ compliance using sustained release quetiapine oral disintegrating tablets[J].Acta Pharmaceut,2016,66:515-531.
|
[22] |
El-Refaie WM,El-Massik MA,Abdallah OY,et al.Formulation and evaluation of taste-masked paracetamol-lipid sachets and chewable tablets[J].J Pharm Investig,2014,44(6):431-442.
|
[23] |
Kharb V,Saharan VA,Kharb V,et al.Formulation and evaluation of lipid based taste masked granules of ondansetron HCl[J].Eur J Pharm Sci,2014,62(4):180-188.
|
[24] |
Jaggupilli A,Howard R,Upadhyaya JD,et al.Bitter taste receptors:Novel insights into the biochemistry and pharmacology[J].Int J Biochem Cell B,2016,77:184-196.
|
[25] |
Pydi SP,Jaggupilli A,Nelson KM,et al.Abscisic acid acts as a blocker of the bitter taste G protein-coupled receptor T2R4[J].Biochemistry,2015,54(16):2622-2631.
|
[26] |
Mancuso G,Borgonovo G,Scaglioni L,et al.Phytochemicals from rutagraveolensactivate TAS2R bitter taste receptors and TRP channels involved in gustation and nociception[J].Molecules,2015,20(10):18907-18922.
|
[27] |
Pydi S P,Sobotkiewicz T,Billakanti R,et al.Amino acid derivatives as bitter taste receptor(T2R)blockers[J].J Biol Chem,2014,289(36):25054-25066.
|
[28] |
Roland WS,Gouka RJ,Gruppen H,et al.6-methoxyflavanones as bitter taste receptor blockers for hTAS2R39[J].PLoS ONE,2014,9(4):e94451-e94451.
|
[29] |
Slack JP,Brockhoff A,Batram C,et al.Modulation of bitter taste perception by a small molecule hTAS2R antagonist[J].Curr Biol,2010,20(12):1104-1109.
|
[30] |
Jaggupilli A,Howard R,Upadhyaya JD,et al.Bitter taste receptors:novel insights into the biochemistry and pharmacology[J].Int J Biochem Cell Biol,2016,77:184-196.
|
[31] |
Deshpande DA, Wang WCH, Mcilmoyle EL, et al.Bitter taste receptors on airway smooth muscle bronchodilate by a localized calcium flux and reverse obstruction[J].Nat Med,2010,16(11):1299-1304.
|
[32] |
Gu F, Liu X, Liang J, et al. Bitter taste receptor mTas2r105 is expressed in small intestinal villus and crypts[J].Biochem Bioph Res Co,2015,463(4):934-941.
|
[33] |
Margolskee RF. Molecular mechanisms of bitter and sweet taste transduction[J].J Biol Chem,2002,277(1):1-4.
|
[34] |
Ming D,Margolskee RF.Blocking taste receptor activation of gustducin inhibits gustatory responses to bitter compounds[J].PNAS,1999,96(17):9903-9908.
|
[35] |
Min JK,Son HJ,Kim Y,et al.Umami-bitter interactions:the suppression of bitterness by umami peptides via human bitter taste receptor[J].Biochem Bioph Res Co,2014,456(2):586-90.
|
[36] |
Keast RSJ,Breslin PAS.Modifying the bitterness of selected oral pharmaceuticals with cation and anion series of salts[J].Pharm Res,2002,19(7):1019-1026.
|
[37] |
Riemer JA.Bitterness inhibitors: US,5336512A[P].1994-08-09[2016-11-25] .
|
[38] |
Cui MM,Ji GQ,Zheng JX.Inhibition effect of ferulic acid on bitterness[J].China Food Addit(中国食品添加剂),2013(1):170-174.
|
[39] |
Mennella JA,Reed DR,Roberts KM,et al.Age-related differences in bitter taste and efficacy of bitter blockers[J].PLoS ONE,2013,9(7):e103-107.
|
[1] | CHEN Xi, JIN Liang. Research progress on sumoylation in type 2 diabetes mellitus[J]. Journal of China Pharmaceutical University, 2025, 56(1): 125-131. DOI: 10.11665/j.issn.1000-5048.2023112002 |
[2] | XIAO Jianqi, XU Jian, SHU Fangrong, HU Xiaofen, LIU Wenyuan, FENG Feng. Effect of Artemisia Argyi Folium ethanolic extract on blood glucose and blood lipids in diabetic mice[J]. Journal of China Pharmaceutical University, 2021, 52(1): 71-76. DOI: 10.11665/j.issn.1000-5048.20210110 |
[3] | MU Jinming, LIU Yue, ZHANG Fangfang, JIN Liang. Relationship between circular RNA and type 2 diabetes and its clinical application[J]. Journal of China Pharmaceutical University, 2020, 51(3): 374-378. DOI: 10.11665/j.issn.1000-5048.20200316 |
[4] | LI Yongrong, CHENG Tao, WANG Yongsheng, LI Qin, GAO Bo, HE Yun, BAI Yu. Effect of extract of selenium-enriched Astragalus membranaceus on insulin resistance in streptozotocin-induced diabetic rats[J]. Journal of China Pharmaceutical University, 2018, 49(6): 739-745. DOI: 10.11665/j.issn.1000-5048.20180616 |
[5] | DU Te, CHEN Jing, SHEN Xu. Research advances in susceptibility genes of non-alcoholic fatty liver disease and its association with type 2 diabetes[J]. Journal of China Pharmaceutical University, 2018, 49(5): 537-544. DOI: 10.11665/j.issn.1000-5048.20180504 |
[6] | CAO Lanjie, ZHU Kuiniu, JIANG Cuihua, GUNN ·Jordan, CHE Chun-Tao, ZHANG Jian, YIN Zhiqi. Intervention effects of the extract of Alismatis Rhizoma on streptozotocin-induced type 2 diabetic rats[J]. Journal of China Pharmaceutical University, 2017, 48(5): 601-608. DOI: 10.11665/j.issn.1000-5048.20170516 |
[7] | WANG Xinning, XU Bin, ZHOU Jinpei, ZHANG Huibin. Advances of anti-diabetic drugs based on new targets[J]. Journal of China Pharmaceutical University, 2015, 46(2): 141-152. DOI: 10.11665/j.issn.1000-5048.20150202 |
[8] | ZHONG Chunmei, MA Yan, WANG Yandong, YANG Wei, HAN Zhong, SUN Jingjing, LIN Baoqin. Effect of Danhong Huayu Koufuye combined with insulin on prevention and progression of early diabetic nephropathy in rats[J]. Journal of China Pharmaceutical University, 2013, 44(6): 568-572. DOI: 10.11665/j.issn.1000-5048.20130616 |
[9] | LI Chen, YUAN Linhua, MA Xueqin, LIU Xiaoquan, XI Tao. Variation of cardiovascular risk biomarkers in type 2 diabetes mellitus[J]. Journal of China Pharmaceutical University, 2013, 44(3): 257-262. DOI: 10.11665/j.issn.1000-5048.20130314 |
[10] | HE Bi-xia, QIAO Li-yun, PENG Jun, XIE Zhi-ping, DING Qi-long. Effects and mechanisms of mifepristone on insulin-resistant HepG 2 cells[J]. Journal of China Pharmaceutical University, 2011, 42(2): 153-159. |